Ann Arbor, Michigan-based Esperion Therapeutics, a pharmaceutical company focused on the development of lipid management drugs to lower cholesterol, has announced a major cost reduction program to reduce costs by $80 million annualized in 2021 and 2022.
The cost-cutting effort will impact 170 to 190 employees or approximately 40% of Esperion's workforce. The company will pick up the slack by expanding its marketing strategy to include more directed digital outreach,
According to the company's recently hired CEO, Sheldon Koenig, “In-person access to health care providers has been negatively impacted by the ongoing COVID-19 pandemic. The firm will focus on “an optimized blend of focused outreach including a streamlined salesforce, directed to targeted cardiologists and primary care physicians, and a suite of digital initiatives.”
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?